Clinical trials
Dermatitis, Atopic trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
211 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 2 |
| 2005 | 1 |
| 2006 | 1 |
| 2008 | 1 |
| 2009 | 4 |
| 2012 | 1 |
| 2013 | 5 |
| 2014 | 7 |
| 2015 | 11 |
| 2016 | 6 |
| 2017 | 12 |
| 2018 | 30 |
| 2019 | 20 |
| 2020 | 10 |
| 2021 | 19 |
| 2022 | 16 |
| 2023 | 23 |
| 2024 | 13 |
| 2025 | 23 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 142 |
| Terminated | 26 |
| Active, not recruiting | 23 |
| Recruiting | 12 |
| Unknown status | 3 |
| Enrolling by invitation | 2 |
| No longer available | 1 |
| Suspended | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 19 |
| LEO Pharma | 15 |
| AbbVie | 13 |
| Eli Lilly and Company | 12 |
| Regeneron Pharmaceuticals | 12 |
| Sanofi | 12 |
| Amgen | 10 |
| Incyte Corporation | 10 |
| Innovaderm Research Inc. | 7 |
| GlaxoSmithKline | 6 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dermatitis, Atopic | 211 |
| Eczema | 86 |
| Dermatitis | 22 |
| Skin Diseases | 21 |
| Pruritus | 12 |
| Immune System Diseases | 9 |
| Genetic Diseases, Inborn | 4 |
| Hypersensitivity | 4 |
| Hypersensitivity, Immediate | 4 |
| Psoriasis | 4 |
Trials
Showing 51 to 75 of 211. Each trial links to its page on Pharma Observatory.
111 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.